1.
Dubovsky
SL
,
Marshall
D
.
Benzodiazepines remain important therapeutic options in psychiatric practice
.
Psychother Psychosom
.
2022
;
91
(
5
):
307
34
.
2.
Rickels
K
,
Moeller
HJ
.
Benzodiazepines in anxiety disorders: reassessment of usefulness and safety
.
World J Biol Psychiatry
.
2019 Sep
;
20
(
7
):
514
8
.
3.
Shinfuku
M
,
Kishimoto
T
,
Uchida
H
,
Suzuki
T
,
Mimura
M
,
Kikuchi
T
.
Effectiveness and safety of long-term benzodiazepine use in anxiety disorders: a systematic review and meta-analysis
.
Int Clin Psychopharmacol
.
2019 Sep
;
34
(
5
):
211
21
.
4.
Gupta
A
,
Bhattacharya
G
,
Farheen
SA
,
Funaro
M
,
Balasubramaniam
M
,
Young
J
,
.
Systematic review of benzodiazepines for anxiety disorders in late life
.
Ann Clin Psychiatry
.
2020 May
;
32
(
2
):
114
27
.
5.
Ogawa
Y
,
Takeshima
N
,
Hayasaka
Y
,
Tajika
A
,
Watanabe
N
,
Streiner
D
,
.
Antidepressants plus benzodiazepines for adults with major depression
.
Cochrane Database Syst Rev
.
2019 Jun 3
;
6
(
6
):
Cd001026
.
6.
Balon
R
.
Who’s afraid of benzodiazepines
.
Psychother Psychosom
.
2022
;
91
(
5
):
291
4
.
7.
Hirschtritt
ME
,
Olfson
M
,
Kroenke
K
.
Balancing the risks and benefits of benzodiazepines
.
JAMA
.
2021
;
325
(
4
):
347
8
.
8.
Gressitt
SE.
Guidelines for the use of benzodiazepines in office practice in the state of Maine
.
Maine Benzodiazepine Study Center, Maine Benzodiazepine Study Group
.
2005
.
Available from:
www.benzos.une.edu.
9.
Center for Prescription Drug Abuse Prevention, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorardo Anschutz Medical Campus
.
Benzodiazepine prescribing guidance
.
2022
.
10.
Kaiser Foundation Health Plan of Washington
.
Benzodiazepine and Z-drug safety guideline
.
2022
.
You do not currently have access to this content.